KIF11 and urinary bladder cancer: Our early study found Eg5 inhibitors as targeted drugs in vivo and in vitro treatment of bladder cancer can have good curative effect, furthermore, we initially demonstrated the anticancer effect of Eg5 inhibitor on gemcitabine resistance bladder cancer in the present paper.